Anew Life Treatment And Training Center, Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 509 N Cassady Ave #201, Bexley, OH 43209 Phone: 614-815-4804 |
Next Generation Behavioral Health Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 2256 1/2 E Main St, Suite C, Bexley, OH 43209 Phone: 800-570-1509 Fax: 800-570-1509 |
Violeta Counseling Services, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2700 E Main St Ste 106, Bexley, OH 43209 Phone: 614-330-0732 |
Alana Moses, Phd, Llc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2342 E Main St, Bexley, OH 43209 Phone: 614-339-3435 |
Optimal Mental Health Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 591 Sheridan Ave, Bexley, OH 43209 Phone: 614-584-2916 |
Yara Counseling Group, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2740 E Main St, Suite B, Bexley, OH 43209 Phone: 614-237-2700 |
News Archive
A review of research carried out over 20 years suggests that UK doctors appear to consistently oppose euthanasia and physician-assisted suicide (PAS). The findings - which appear in the latest issue of the journal Palliative Medicine, published by SAGE - highlight a gap between doctors' attitudes and those of the UK public.
Boston Scientific Corporation today announced the U.S. and European launches of the SterlingĀ® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets.
In this global development podcast, the Guardian's Annie Kelly is joined by Julia Bunting, head of the U.K. Department for International Development's reproductive health team; Yasmin Ahmed, senior regional director for Asia at Marie Stopes International; Neil Datta, coordinator of the European Parliamentary Forum on Population and Development; and Gita Sen, professor at the Centre for Public Policy at the Indian Institute of Management, for a discussion about family planning ahead of the July 11 London Summit on Family Planning.
A study conducted by researchers at Thomas Jefferson University, Philadelphia, and published Tuesday, July 27, 2004, in the journal Neurology, shows that Frova (frovatriptan), a triptan class migraine therapy with a long half life, significantly reduced the incidence of menstrual associated migraines (MAM) in women who took the medication preventively, in advance of anticipated onset of headache.
A new study looking at deaths from cancer, cardiovascular disease and all causes suggests that an inflammatory marker detected in blood tests in middle-aged adults can better predict the risk of death compared with another similar biomarker.
› Verified 4 days ago